Lisa Crocker

Targeting HER2-Positive Breast Cancer with Trastuzumab-DM1, an Antibody–Cytotoxic Drug Conjugate

Gail D. Lewis Phillips, Guangmin Li, Debra L. Dugger et al. · Cancer Research · 2008 · 1.6K citations

Drug Targeting, Breast Oncology, Disulfide Linkers +12

A Central Role for HER3 in <i>HER2</i> -Amplified Breast Cancer: Implications for Targeted Therapy

Si Tuen Lee-Hoeflich, Lisa Crocker, Evelyn Yao et al. · Cancer Research · 2008 · 642 citations · Full text

A Two-in-One Antibody against HER3 and EGFR Has Superior Inhibitory Activity Compared with Monospecific Antibodies

Gabriele Schaefer, Lauric Haber, Lisa Crocker et al. · Cancer Cell · 2011 · 332 citations · Full text

Immunocytochemical Technique, Allergy, Autoimmune Disease +9

Single-Cell Dynamics Determines Response to CDK4/6 Inhibition in Triple-Negative Breast Cancer

Uzma Asghar, Alexis R. Barr, Ros Cutts et al. · Clinical Cancer Research · 2017 · 274 citations · Full text

Superior <i>In vivo</i> Efficacy of Afucosylated Trastuzumab in the Treatment of HER2-Amplified Breast Cancer

Teemu T. Junttila, Kathryn L. Parsons, Christine Olsson et al. · Cancer Research · 2010 · 216 citations · Full text